Pharmaceutical Preparations
| Institution | Shares | Value | Ownership % | Change | Filing Date |
|---|---|---|---|---|---|
| RA CAPITAL MANAGEMENT, L.P. | 10.81M | $30.0M | 14.50% | -- | 2026-06-30 |
| BlackRock, Inc. | 6.30M | $17.0M | 8.46% | +1.79M | 2026-06-30 |
| NEA Management Company, LLC | 3.57M | $10.0M | 4.79% | -- | 2026-06-30 |
| SAMSARA BIOCAPITAL, LLC | 3.51M | $9.0M | 4.71% | -- | 2026-06-30 |
| SR One Capital Management, LP | 3.33M | $9.0M | 4.47% | -- | 2026-06-30 |
| GSK plc | 3.15M | $8.0M | 4.23% | -- | 2026-06-30 |
| Monaco Asset Management SAM | 2.37M | $6.0M | 3.19% | -148.5K | 2026-06-30 |
| CITADEL ADVISORS LLC | 2.26M | $6.0M | 3.03% | +450.7K | 2026-06-30 |
| VANGUARD CAPITAL MANAGEMENT LLC | 2.23M | $6.0M | 2.99% | +215.0K | 2026-06-30 |
| TWO SIGMA INVESTMENTS, LP | 1.87M | $5.0M | 2.51% | -- | 2026-06-30 |
